Biomarkers such as HPV DNA/mRNA, HPV-E6, EBV RNA, p16^Ink4a, and the more recently identified NNMT and PON2 play critical roles in the diagnosis, prognosis, and prediction of treatment response in head and neck squamous cell carcinoma (HNSCC). Here, PON2 is linked to head and neck squamous cell carcinoma.